Autopsy report · NCT02045095
A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors
Cause of deathNo reason given
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years 9 months before it stopped.
- 29 participants enrolled.
- Results were posted on the registry 2 years 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Sponsor type
- Industry
- Conditions
- Advanced Malignant Solid Tumors
- Interventions
- MLN7243
- Participants
- 29
- Sites
- 7
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.